Tilray

Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 13 countries spanning five continents. Tilray supports clinical and observational studies in Canada, the United States, the European Union, and Australia, examining the efficacy of medical cannabis as a treatment for pediatric epilepsy, essential tremor, post-traumatic stress disorder, and alcohol use disorder, and to address the side effects of cancer chemotherapy.

Content by Tilray

can medical cannabis reduce alcohol dependency?
| 2 min read
Page 1 of 1 - 1 Total Items

CURRENT ISSUE - January/February 2025

Energizing Leadership in Action

The science-backed behaviors that help leaders inspire thriving teams and organizations

Lab Manager January/February 2025 Cover Image